Yükleniyor... / Loading...

Prothrombin G20210A Mutation — Gene Therapy & Clinical Trials | FollowGene

Features Diseases How It Works?Approved TherapiesSign In

The information on this page is for informational purposes only and does not constitute medical advice. Consult your genetic counselor or specialist physician for treatment decisions.

Home/Diseases/Prothrombin G20210A Mutation

Prothrombin G20210A Mutation

Prevalence: 1/50

hematologic

Official·OMIM:176930

Thromboembolism predisposition due to G20210A mutation in F2 gene.

Associated Genes

F2Coagulation Factor II

Chromosome 11Autosomal Dominant

FollowGene

Clinical trial tracking for CRISPR, gene therapy, and rare genetic diseases — a reliable source of information for patients, families, and researchers.

Links

About Us
Blog
Contact

Legal

FollowGene does not provide medical advice. The information here is for informational purposes only. Always consult a healthcare professional for your health decisions.

© 2026 FollowGene. All rights reserved.

Privacy Policy Terms of Use